Beta Drugs Ltd.
BETA Share PricePharmaceuticals & Drugs
₹1,671.4
-19.2 (-1.1%)
As on December 4, 2025
Exchange Scrips: BSENSEBETAISININE351Y01019
Market Cap ₹ 0 Cr
P/E Ratio 39.78
Dividend Yield N/A
Performance
Market performance
Open1,734.9
High1,734.9
Volumes2,328
Prev1,671.4
Low1,605
As on2025-12-04
Historical performance
1 Year High2,190.48
3 Year High2,215.24
5 Year High2,215.24
1 Year Low1,429.52
3 Year Low571.43
5 Year Low99.81
Fundamentals
Company Valuation
Market Cap (₹Cr)
0
Face Value (₹)
10
P/E Ratio
39.78
Dividend Yield
N/A
Investment Returns
1 Year
-21.7%
3 Years
143.7%
5 Years
1381%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,699.32 | Bearish |
| 10-DMA | 1,673.06 | Bearish |
| 20-DMA | 1,669.01 | Bullish |
| 50-DMA | 1,746.98 | Bearish |
| 100-DMA | 1,777.86 | Bearish |
| 200-DMA | 1,774.16 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 3179 | 3134 | 3049 | 2877 | 2562 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 39.78.
- 3Y Stock Price CAGR of the stock is 34.0.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹810 Million.
- The company generated revenue of ₹3624 Million in the previous financial year.
Beta Drugs Ltd.
1671.4-19.2 (-1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 782490.6
No. of Shares: 468 (Approx)
Performance:-21.8%
P/L: ₹-217509.4
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
